Free Trial

Universe Pharmaceuticals (UPC) SEC Filings & 10K Form

Universe Pharmaceuticals logo
$0.64 +0.00 (+0.31%)
(As of 12/20/2024 05:40 PM ET)

Recent Universe Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/12/2024
3:31 PM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
7:02 AM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
3:00 PM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:05 PM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2024
3:05 PM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2024
11:15 PM
Universe Pharmaceuticals (Filer)
Form EFFECT
05/14/2024
3:06 PM
Universe Pharmaceuticals (Filer)
Form F-1/A
04/24/2024
4:13 PM
Universe Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
02/07/2024
7:00 AM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2024
11:05 AM
Universe Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:UPC) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners